[In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma].
Kunze
D
D
Klinik für Urologie, Medizinische Fakultät, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden. Doreen.kunze@uniklinikum-dresden.de
Füssel
S
S
Meye
A
A
Wuttig
D
D
Krämer
K
K
Kotzsch
M
M
Toma
M
M
Schwenzer
B
B
Kausch
I
I
Jocham
D
D
Hakenberg
O W
OW
Grimm
M O
MO
Wirth
M P
MP
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D009368:Neoplasm Transplantation; D020319:Oligodeoxyribonucleotides, Antisense / Q000627:therapeutic use*; D034741:RNA, Small Interfering / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured / Q000187:drug effects*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology
D014408:Biomarkers, Tumor; D020319:Oligodeoxyribonucleotides, Antisense; D034741:RNA, Small Interfering